Altshuler Shaham’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Altshuler Shaham’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-576,345	Closed	-$3.66K	–	427
2024 Q4	$3.66K	Hold	576,345	–	–	﹤0.01%	330
2024 Q3	$3.62K	Hold	576,345	–	–	﹤0.01%	283
2024 Q2	$16.3K	Buy	576,345 +510	+0.1%	+$27	﹤0.01%	199
2024 Q1	$51.8K	Sell	575,835 -510	-0.1%	-$49	﹤0.01%	97
2023 Q4	$60.7K	Hold	576,345	–	–	﹤0.01%	105
2023 Q3	$130K	Hold	576,345	–	–	﹤0.01%	99
2023 Q2	$151K	Hold	576,345	–	–	﹤0.01%	106
2023 Q1	$104K	Sell	576,345 -2,500	-0.4%	-$572	﹤0.01%	141
2022 Q4	$116K	Buy	+578,845	New	+$248K	﹤0.01%	119

Other funds holding DNA.WS

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.35B AUM 34.37% 1-Year Est. Return

Altshuler Shaham's DNA.WS Position: Q1 2025 in Review

Altshuler Shaham sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q1 2025, closing a stake of 576,345 shares — an estimated $3.66K sold.

Altshuler Shaham first reported a position in DNA.WS in Q4 2022 and held it in 9 quarters. The position peaked at $151K in Q2 2023. 3 funds tracked by Wall St. Rank hold DNA.WS as of Q1 2025.

Altshuler Shaham reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q1 2025 after selling out during the quarter.
Altshuler Shaham sold 576,345 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q1 2025, an estimated $3.66K.
Altshuler Shaham first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q4 2022 and held it in 9 quarters.
Altshuler Shaham's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $151K in Q2 2023.
3 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q1 2025.

Based on Altshuler Shaham's 13F filing for Q1 2025, filed 15 May 2025.